SCHEMBL23747422

SCHEMBL23747422

COc1ccc(CNC(=O)Nc2ccc(CC(=O)N3CCC(c4ccccc4)C3)cc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.76
▸ RAB9A P51151 4/20 0.76
▸ LMNA P02545 2/20 0.76
▸ NPC1 O15118 3/20 0.61
▸ POLB P06746 1/20 0.58
▸ GLA P06280 1/20 0.54
▸ MAPT P10636 3/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.53
▸ STAT1 P42224 1/20 0.53
▸ HPGD P15428 3/20 0.51
▸ GAA P10253 1/20 0.51
▸ JAK3 P52333 1/20 0.51
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ CCR3 P51677 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.49
▸ MCL1 Q07820 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ GRIN2B Q13224 1/20 0.48
▸ HDAC1 Q13547 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23747551 0.85 SMN1; SMN2 (0.57) ALDH1A1RAB9ALMNANPC1POLB
SCHEMBL26101046 0.84 NAMPT (0.59) ALDH1A1RAB9ALMNANPC1SMN1; SMN2
SCHEMBL23747787 0.84 SMN1; SMN2 (0.55) ALDH1A1RAB9ALMNANPC1POLB
SCHEMBL23747788 0.84 SMN1; SMN2 (0.55) ALDH1A1RAB9ALMNANPC1POLB
SCHEMBL26550269 0.83 SMN1; SMN2 (0.59) ALDH1A1RAB9ALMNANPC1POLB
SCHEMBL19961363 0.83 ALDH1A1 (0.72) ALDH1A1RAB9ALMNANPC1POLB
SCHEMBL23747806 0.83 SMN1; SMN2 (0.64) ALDH1A1RAB9ANPC1POLBMAPT
SCHEMBL26546709 0.83 SMN1; SMN2 (0.64) ALDH1A1RAB9ANPC1POLBMAPT
SCHEMBL26099137 0.82 SMN1; SMN2 (0.58) ALDH1A1RAB9ALMNANPC1POLB
SCHEMBL26132373 0.82 SMN1; SMN2 (0.62) ALDH1A1RAB9ANPC1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 — — US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 — — US disclosed
WO-2021159015-A1 NAMPT MODULATORS CYTOKINETICS, INC. (US) 2021-08-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 ALDH1A1 2019/4885RAB9A 807/4885LMNA 2810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback